At this stage, traditional Chinese medicine mainly acts on NF-κB, Wnt/β-catenin, MAPK, TGF-β and other pathways to improve the inflammatory microenvironment, inhibit the proliferation and activation of gastric cancer cells, promote their apoptosis and thus slow down the progression of gastric cancer. Here, TGFB1 is linked to gastric cancer.